RARE DISEASES A–Z · LETTER A

Alport Syndrome

Alport syndrome is an inherited condition in which a fault in a type of collagen — the scaffolding protein of basement membranes — weakens the filters of the kidneys, and often the inner ear and the lens of the eye as well. It is one of the classic hereditary causes of progressive kidney disease in children and young adults.

By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026

Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.

In short: Alport syndrome is a genetic collagen fault that damages kidney filters, causing blood and protein in the urine and, in many, gradual kidney failure. It often affects hearing and eyes too. Blood-pressure medicines that protect the kidney slow it down.

The guide

The basics

Healthy kidney filters rely on type IV collagen to stay strong while letting waste through. In Alport syndrome, changes in one of three collagen genes (COL4A3, COL4A4, or COL4A5) make that mesh fragile. The first sign is usually blood in the urine, often invisible and picked up on a urine test in childhood; protein leakage follows, then slowly rising blood pressure and falling kidney function. The same collagen is used in the cochlea, so hearing loss — typically for high-pitched sounds, starting in later childhood or the teens — is common, and characteristic eye changes can affect the lens and retina. The X-linked form (COL4A5) mainly affects boys and men more severely, though women who carry it also need lifelong monitoring.

How it works

Doctors suspect Alport syndrome when blood in the urine runs in a family alongside kidney failure or hearing loss. Genetic testing is now the main way to confirm it and identifies exactly which gene and inheritance pattern are involved, which guides family screening and prognosis. A kidney biopsy, sometimes used when genetics are inconclusive, shows characteristic splitting and thinning of the filter membrane under the electron microscope. Hearing tests and an eye examination complete the picture. Because early treatment changes the outcome, guidelines encourage testing children in affected families rather than waiting for symptoms — a urine test for blood and protein is the simple first step.

Day to day

There is no treatment that repairs the collagen, but progression can be slowed substantially. Blood-pressure medicines of the ACE inhibitor class — and, if needed, related blockers — reduce protein leakage and protect the kidney, and starting them early, even before protein appears in some cases, improves long-term outcomes. Salt restriction, not smoking, and avoiding medicines that strain the kidneys all help. Hearing aids manage hearing loss well, and most eye changes need monitoring rather than treatment. If kidney failure does develop, dialysis and transplantation work as they do for other causes — and transplantation outcomes are generally good, though living related donors must be screened carefully because they may carry the same gene.

When to get help

Care is shared between kidney specialists, audiology, and eye clinics, with regular checks of kidney function, urine protein, and blood pressure. Family planning conversations benefit from genetic counselling: inheritance differs by gene — X-linked, autosomal recessive, or autosomal dominant — and testing relatives, especially potential kidney donors, is important. Newer therapies aimed at the underlying disease are in clinical trials, so asking about research registries is worthwhile. Seek prompt advice for visible blood in the urine with pain or fever (which may be an unrelated infection or stone), a sudden drop in hearing, or any rapid swelling, which can signal a faster phase of kidney decline.

See a doctor promptly if: Rapid swelling of the face or legs, breathlessness, or a large drop in urine output in someone with kidney disease needs same-day medical assessment.

Common questions

Is Alport syndrome the same in boys and girls?

It depends on the gene. The commonest form is X-linked: boys, who have one X chromosome, usually develop kidney failure in early adult life, while girls and women range from mild urine changes only to kidney failure later in life. The autosomal forms affect the sexes more equally.

Can treatment really slow Alport syndrome down?

Yes. Studies of ACE inhibitor treatment started early show a meaningful delay in reaching kidney failure — in some analyses, years of extra kidney function. That is why early genetic diagnosis and starting protection before heavy protein leakage are emphasised.

Should my children be tested?

Generally yes. A simple urine test for blood and protein, and genetic testing where the family variant is known, can identify affected children early enough for protective treatment to help most. Your kidney team or genetic counsellor can arrange a family plan.

Can someone with Alport syndrome receive a kidney transplant?

Yes — transplantation is a standard, successful treatment when kidney failure develops. The new kidney has normal collagen, so Alport syndrome does not come back in it, although teams watch for a rare immune reaction to the new collagen. Related donors are screened for the gene first.

More in Letter A

Related

Sources

This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Kidney-protective treatment and family screening plans are individual; follow your kidney team's advice.